Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Eosinophilic Duodenitis (EoD)”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Large-scale testing (Phase 3)Study completedNCT04856891
What this trial is testing

Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis

Who this might be right for
Eosinophilic DuodenitisEosinophilic Gastroenteritis
Allakos Inc. 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT05831176
What this trial is testing

Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have

Who this might be right for
Eosinophilic Gastritis (EoG)Eosinophilic Duodenitis (EoD)Eosinophilic Gastrointestinal Disease (EGID)+1 more
Regeneron Pharmaceuticals 22
Testing effectiveness (Phase 2)Study completedNCT03664960
What this trial is testing

An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

Who this might be right for
Eosinophilic GastritisEosinophilic GastroenteritisEosinophilic Duodenitis
Allakos Inc. 58
Large-scale testing (Phase 3)WithdrawnNCT05152563
What this trial is testing

Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis

Who this might be right for
Eosinophilic GastritisEosinophilic Duodenitis
Allakos Inc.